Design Therapeutics logo

Design Therapeutics

Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.


Employees

51-200

Links


Org chart


Board & advisors


Teams


Offices